Lutropin Alfa
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00044 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 32 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | postural orthostatic tachycardia syndrome | KG + DL |
| 2 | peptic esophagitis | KG + DL |
| 3 | trichotillomania | KG + DL |
| 4 | Raynaud disease | KG + DL |
| 5 | duodenal ulcer (disease) | KG + DL |
| 6 | Tourette syndrome | KG + DL |
| 7 | esophageal disease | KG + DL |
| 8 | sinoatrial block | KG + DL |
| 9 | multiple endocrine neoplasia | KG + DL |
| 10 | duodenogastric reflux | KG + DL |
| 11 | duodenal obstruction | KG + DL |
| 12 | sinoatrial node disease | KG + DL |
| 13 | non-syndromic esophageal malformation | KG + DL |
| 14 | amenorrhea (disease) | KG + DL |
| 15 | active peptic ulcer disease | KG + DL |
| 16 | esophageal ulcer | KG + DL |
| 17 | progressive familial heart block | KG + DL |
| 18 | adrenal gland hyperfunction | KG + DL |
| 19 | peptic ulcer perforation | KG + DL |
| 20 | gastrojejunal ulcer | KG + DL |
| 21 | His bundle tachycardia | KG + DL |
| 22 | glaucoma | KG + DL |
| 23 | seborrheic dermatitis | KG + DL |
| 24 | multiple system atrophy | KG + DL |
| 25 | overactive bladder (disease) | KG + DL |
| 26 | dyskinesia of esophagus | KG + DL |
| 27 | esophageal atresia (disease) | KG + DL |
| 28 | esophageal tuberculosis | KG + DL |
| 29 | esophageal leukoplakia (disease) | KG + DL |
| 30 | esophageal malformation | KG + DL |
| 31 | esophageal diverticulosis | KG + DL |
| 32 | open-angle glaucoma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.